Mammalian target of rapamycin and head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival....
Main Authors: | Liao, Yu-Min, Kim, Charles, Yen, Yun |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108931/ |
Similar Items
-
Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
by: Huang, Chuan-En, et al.
Published: (2014) -
Hypoxia in Head and Neck Squamous Cell Carcinoma
by: Li, John Zenghong, et al.
Published: (2012) -
Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
by: Gandhi, Mitul D, et al.
Published: (2014) -
Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling
by: Aminuddin, Amnani, et al.
Published: (2016) -
Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Gurudutt, Vivek V., et al.
Published: (2011)